Medically reviewed by Dr. Giovanni Scornavacca — Hair Restoration Specialist, Carisma Hair Clinic, St Julian's, Malta. 20+ years clinical experience, trained in Rome and Bologna.

Medically reviewed by Dr. Giovanni Scornavacca — Hair Restoration Specialist, Carisma Hair Clinic, St Julian's, Malta. 20+ years clinical experience.

Finasteride in Malta: Where to Get It and What to Know

Finasteride is a prescription medication that reduces the hormone responsible for male pattern hair loss by approximately 70%. Clinical trials show it stabilises hair loss in the large majority of men and produces visible regrowth at the crown in around two-thirds of patients. In Malta, finasteride requires a prescription from a licensed medical professional and is not available over the counter. Results may vary for each individual.

There is a specific moment many men describe in a similar way. It happens in a particular light — morning light, usually, or the harsh fluorescent of a public bathroom. The hairline looks different from how it did a year ago. The crown sits lower than it used to. The thought that follows is rarely dramatic. It is more like a quiet recognition: this is happening, and it has been happening for a while.

If that recognition has led you to research finasteride Malta, you are already ahead of most men. The majority who notice hair loss either dismiss it, wait years before seeking help, or end up buying something unregulated online in the hope that it works. None of those paths leads anywhere useful.

Finasteride, when used correctly, is one of the most clinically well-established medications in hair loss medicine. It is also a prescription drug with a specific mechanism, a clear evidence base, and a side effect profile that deserves honest discussion. This article covers all of it — what the medication does, what the clinical data shows, how to access it properly in Malta, and who it is and is not appropriate for.

Contents

• ›How Finasteride Works: The DHT Mechanism
• ›The Clinical Evidence: What the Trials Actually Show
• ›Finasteride in Malta: How to Access It Properly
• ›Who Is a Candidate for Finasteride
• ›Side Effects: An Honest Assessment
• ›A Malta-Specific Consideration: Sun, Scalp, and DHT
• ›What to Expect: A Realistic Timeline
• ›Frequently Asked Questions About Finasteride Malta

How Finasteride Works: The DHT Mechanism

Hair loss in men with androgenetic alopecia — the clinical term for male pattern baldness — is driven by a hormone called dihydrotestosterone, or DHT. DHT is produced when testosterone is converted by an enzyme called type II 5-alpha reductase. In genetically susceptible hair follicles, DHT binds to androgen receptors and initiates a slow process of follicular miniaturisation: each hair growth cycle produces a slightly thinner, shorter hair shaft, until the follicle eventually becomes dormant.

Finasteride works by selectively inhibiting type II 5-alpha reductase — the same enzyme driving this process. In a clinical study of 249 men, a 1 mg daily dose of finasteride reduced serum DHT by approximately 71% and scalp DHT by approximately 64%. This reduction in localised DHT exposure is what interrupts the miniaturisation process in susceptible follicles. Clinical studies indicate this mechanism is well-established across multiple peer-reviewed trials, including the original finasteride randomised controlled trial.

This is the core of why finasteride is effective: it does not regrow hair by stimulating follicles directly. It removes the primary signal that is causing those follicles to fail. Where follicles retain enough biological capacity to recover — which in early-to-moderate hair loss is quite a few — reducing DHT allows them to return towards normal cycling.

The medication does not affect testosterone directly. Libido, muscle mass, and energy levels are not systematically impacted at the 1 mg therapeutic dose. The androgenic functions mediated by testosterone itself remain intact.

This is the relevant biological context for men in Malta considering this medication. Understanding what finasteride is targeting — and what it is not touching — is the foundation for an informed decision.

{width="940" height="650" loading="lazy"} Finasteride is a prescription-only medicine across the EU, including Malta. It is not available over the counter.

The Clinical Evidence: What the Trials Actually Show

Finasteride has one of the most extensive clinical trial programmes in hair loss medicine. The pivotal data comes from large, long-term, placebo-controlled randomised trials funded as part of the registration programme, and the findings have been replicated and summarised across multiple peer-reviewed publications.

Stabilisation — stopping further loss

In a two-year randomised controlled trial, 83% of men treated with finasteride showed no further hair loss at the vertex (crown) compared to placebo. At the frontal hairline, 70% showed stabilisation at one year. These figures are frequently cited in clinical summaries and represent the medication's most reliable effect: arresting progression.

Regrowth — recovering what was lost

Visible regrowth at the vertex was observed in approximately 61–66% of finasteride-treated men at two years. Frontal area regrowth occurred in approximately 37% of men at one year. The regrowth effect is strongest at the crown and weaker at the frontal hairline — a distinction that matters when setting expectations. Evidence suggests the frontal hairline is less responsive than the vertex to DHT reduction alone.

What these numbers mean in practice

The correct interpretation of this data is that finasteride may reliably slow or stop further loss in the majority of men, and may produce meaningful regrowth at the crown in a substantial proportion. It is not a universal cure, and results vary considerably by stage of hair loss and by individual androgen receptor sensitivity. Men with more advanced hair loss — or follicles that have been dormant for many years — will see less regrowth, though they may still benefit from stabilisation.

A systematic review published in the Journal of the American Academy of Dermatology confirmed these findings across multiple randomised controlled trials, reinforcing finasteride's status as the most evidence-backed oral medication for androgenetic alopecia in men.

One further important point from the clinical data: finasteride's effects are dependent on continued use. Hair loss typically resumes within months of stopping the medication. The treatment maintains, rather than permanently corrects, the underlying hormonal influence.

For men seeking hair loss treatment Malta, understanding what kind of result is realistic for their current stage is one of the most important questions a clinical consultation can answer.

Finasteride in Malta: How to Access It Properly

This is the section that most online articles skip, and it matters considerably for patients in Malta.

Finasteride is a prescription-only medicine (POM) in Malta and across the entire European Union. It is not available over the counter, from a pharmacy without a prescription, or from a supplement retailer. The branded version (Propecia, 1 mg) and generic equivalents both require a valid prescription from a licensed medical professional.

This is a regulatory fact, not a commercial arrangement. The prescription requirement exists because finasteride has a defined therapeutic indication, a side effect profile that requires medical oversight, and is absolutely contraindicated in women who are pregnant or may become pregnant (more on this below).

How to get finasteride prescribed in Malta:

1. ›Book a consultation with a licensed physician or dermatologist who can assess your hair loss — its pattern, stage, and likely cause.
2. ›The prescribing doctor will take a brief medical history, assess for contraindications, and confirm that androgenetic alopecia is the likely diagnosis.
3. ›A prescription is issued, which can be filled at any Maltese pharmacy carrying the medication or its generic equivalents.
4. ›Ongoing monitoring is standard — a follow-up assessment at 6–12 months is appropriate to evaluate response.

The online alternative — and why it carries risk

A significant number of men obtain finasteride through online platforms that offer remote prescriptions, sometimes with minimal medical screening, or through entirely unregulated sources. The risks are not trivial. First, an unregulated product may not contain what it claims, or may contain incorrect dosing. Second, finasteride is not appropriate for all men: it is contraindicated in certain liver conditions and carries serious risks if handled by women of childbearing age. Third, without a clinical assessment, there is no way to confirm that androgenetic alopecia is the actual cause of the hair loss.

A clinical consultation in Malta — such as the assessment offered through Carisma Hair Clinic's Hair Reset Protocol — provides scalp imaging and density mapping before any treatment recommendation is made. This step is what separates a well-managed treatment from one that has been started without adequate assessment.

If you are looking to understand the differences between available prescription options, comparing finasteride with minoxidil is a logical next step — you can find that comparison in our dedicated article.

Who Is a Candidate for Finasteride

Finasteride is indicated for adult men with androgenetic alopecia — the genetically driven, DHT-mediated form of hair loss that produces the characteristic receding hairline, crown thinning, or both. Evidence suggests this is one of the most prevalent forms of hair loss in men, affecting approximately 50% of men by age 50, according to a comprehensive androgenetic alopecia review.

The clinical trial populations that generated the evidence for finasteride were predominantly men in Norwood stages II–IV. This is where the medication has the strongest supporting data: hair loss is active, follicles have not been permanently dormant, and the DHT reduction can interrupt ongoing miniaturisation.

Men in earlier stages (Norwood I–II) can benefit particularly from finasteride as a preventive measure — the earlier DHT suppression begins, the more follicles are preserved before irreversible miniaturisation occurs. Men in later stages (Norwood V–VII) are less likely to see significant regrowth, though some may still benefit from preventing further progression.

Good candidates typically share the following characteristics:

• ›Adult men (18 and over) with confirmed androgenetic alopecia
• ›Active or progressive hair loss — not hair loss that stabilised years ago
• ›Norwood stages approximately I–V
• ›No contraindicated medical conditions
• ›A clear understanding of the maintenance requirement and realistic expectations about results

Who is not a candidate

Women of childbearing potential must not take finasteride under any circumstances. Finasteride carries a Category X pregnancy classification — animal studies have demonstrated dose-dependent fetal abnormalities, specifically relating to normal male genital development, when the fetus is exposed to 5-alpha reductase inhibitors during gestation. Women who are pregnant or may become pregnant must not even handle crushed or broken finasteride tablets, as absorption through skin contact is possible.

In post-menopausal women, finasteride is sometimes used off-label for female pattern hair loss, but the evidence base at the 1 mg dose is mixed — a 137-patient randomised trial found no significant effect versus placebo. Higher off-label doses show more encouraging results in some observational studies. Any use in women requires specialist supervision.

Men with significant liver impairment should discuss their medical history before starting finasteride, as the drug is metabolised hepatically.

Side Effects: An Honest Assessment

The side effect that most men research when considering finasteride is sexual dysfunction — decreased libido, erectile dysfunction, and ejaculation changes. The clinical data are clear on the frequency: in a phase III randomised controlled trial, sexual adverse events were reported in approximately 4.8% of men taking oral finasteride 1 mg, compared to 3.3% in the placebo group. The absolute difference is small, but it is not zero.

For the majority of men who experience these effects, they may resolve after stopping the medication. The evidence does not support a guarantee of resolution, and a small number of patients have reported symptoms persisting after discontinuation (sometimes referred to as post-finasteride syndrome). The medical literature on persistent effects is still developing, and the prevalence is unknown. The FDA updated the finasteride label in 2012 to include a warning about potentially persistent sexual effects.

This does not mean the risk should be catastrophised. The clinical trial populations — thousands of men across multi-year trials — consistently show that the majority of users do not experience sexual side effects, and that those who do most commonly see resolution. But it does mean that this is a decision to make with full information and with a doctor who can answer your specific questions.

Topical finasteride as an alternative

A phase III randomised trial published in 2022 compared topical finasteride spray directly to oral finasteride 1 mg and placebo. Hair count outcomes were numerically equivalent. However, systemic DHT reduction was approximately 40% lower with the topical formulation (serum DHT reduction: 34.6% topical vs. 55.6% oral), and the rate of sexual adverse events was lower in the topical group (2.8%) compared to the oral group (4.8%). This has made topical finasteride an increasingly used option for men who want comparable efficacy with reduced systemic exposure.

If you want to explore whether this alternative may be appropriate for you, topical finasteride is also available in Malta and the clinical evidence for it is outlined in a dedicated article. You may also find it useful to understand the potential side effects in detail before deciding.

A Malta-Specific Consideration: Sun, Scalp, and DHT

There is a factor in the Maltese context that is underappreciated in most general hair loss content.

Malta's ultraviolet index reaches 9–10 and higher in summer months — classified as Very High to Extreme by the World Health Organization. Chronic, unprotected UV exposure to the scalp has been associated in some observational research with accelerated follicular ageing and oxidative stress in hair follicles. While UV is not a primary driver of androgenetic alopecia — DHT is — it may represent an aggravating factor for men whose follicles are already under androgen-mediated stress.

This does not mean finasteride is more or less effective in Malta. But it does mean that men here who are outdoors regularly — on the water, on construction sites, at sporting events — are operating in a UV environment that offers minimal natural scalp shielding for men with any degree of thinning. Scalp sun protection is a straightforward adjunct to medical treatment — raise it at any clinical consultation.

Malta's Mediterranean diet — relatively high in protein, omega-3 fatty acids, and micronutrients such as zinc and biotin — is broadly supportive of general hair health. Severe nutritional deficiencies are less common here than in regions with poorer diet quality, but blood testing remains appropriate when hair loss is sudden, diffuse, or atypical. A clinical assessment through a non-surgical hair regrowth programme will typically include this evaluation.

What to Expect: A Realistic Timeline

If finasteride is prescribed and used consistently, the expected trajectory is as follows:

Months 1–3: No visible change is expected at this stage, and this is normal. The medication is working at a hormonal level — reducing scalp DHT — before any visible follicular response is apparent. Some men notice reduced shedding in this window, which is a positive signal.

Months 3–6: The first signs of response typically become noticeable here. For some men, this is reduced shedding. For others, early regrowth of finer hairs at the crown. Progress is subtle at this stage; a baseline photograph is helpful for comparison.

Months 6–12: The range of response begins to differentiate between individuals. Men who respond well typically see measurable improvement in crown density. Men whose loss was more advanced may see stabilisation without significant regrowth. A 12-month clinical assessment is the standard benchmark for evaluating whether to continue, adjust, or combine treatments.

Beyond 12 months: For men who respond to finasteride, gains tend to be maintained with continued use. Long-term data from the registration trials show durable benefit over multiple years of consistent treatment.

The consistent message across clinical evidence is that how long finasteride takes to work is at minimum several months — patience and consistency are prerequisites for any meaningful result.

Frequently Asked Questions About Finasteride in Malta

Is finasteride available in Malta?

Yes. Finasteride (as the branded product Propecia 1 mg or generic equivalents) is available in Malta through licensed pharmacies. It requires a prescription from a qualified medical professional. It is not available over the counter or without a clinical assessment. If you are unsure where to start, a structured hair loss consultation at Carisma Hair Clinic in St Julian's provides a clinical assessment and, where appropriate, a prescription pathway.

Do I need a prescription for finasteride in Malta?

Yes, without exception. Finasteride is a prescription-only medicine (POM) across the European Union, including Malta. Any source offering it without a prescription is operating outside licensed channels, and the product quality and dosing accuracy cannot be verified. A licensed consultation is the only appropriate way to access finasteride in Malta.

How much does finasteride cost in Malta?

The cost of finasteride in Malta varies depending on whether you use the branded product (Propecia) or a generic equivalent. Generic finasteride 1 mg is considerably more affordable and contains the same active ingredient. At Carisma Hair Clinic, an initial hair loss consultation is offered free of charge, which includes scalp imaging and a treatment assessment. Contact us for current pricing on any prescription protocol.

How long does finasteride take to work?

Most men see the first signs of response — reduced shedding or early regrowth — between months three and six of consistent daily use. A meaningful assessment of overall efficacy requires 12 months of treatment. Hair loss that has been active for years will not reverse within weeks; the follicular recovery process mirrors the timeline over which the damage accumulated, at a compressed but still gradual pace.

What are the side effects of finasteride?

The most discussed side effects are sexual — decreased libido, erectile dysfunction, and changes in ejaculation — reported in approximately 2–5% of men in clinical trials. For most men who experience these effects, they may resolve after stopping the medication. A small number of men have reported effects persisting after discontinuation; the prevalence of this is unknown. Non-sexual side effects are uncommon. Before starting, discuss your full medical history and any concerns with your prescribing doctor. A detailed overview of the side effect profile is available at our dedicated article on finasteride side effects.

Is finasteride safe for long-term use?

Clinical evidence indicates that finasteride is generally well-tolerated during long-term use in men with androgenetic alopecia. Studies following patients over five or more years show no new safety signals beyond those identified in initial trials. That said, annual reviews with your prescribing doctor are advisable to monitor for any changes. Safety profiles can differ between individuals, and this should always be discussed with your healthcare provider.

Can women take finasteride?

Women of childbearing potential must not take finasteride. The medication is absolutely contraindicated during pregnancy, as animal studies have confirmed dose-dependent fetal abnormalities during male genital development. Women who are pregnant or may become pregnant must not handle crushed or broken tablets. In post-menopausal women, finasteride is sometimes used off-label under specialist supervision, but the evidence at the 1 mg dose is mixed and a specialist assessment is required.

What happens if I stop taking finasteride?

The effects of finasteride are dependent on continued use. The medication works by suppressing DHT while it is being taken; once stopped, DHT levels return to baseline, and the underlying androgenetic process resumes. Clinical studies indicate that hair gains are typically lost within 6–12 months of stopping. This is why treatment is considered long-term maintenance rather than a course with an endpoint.

Ready to Take Control of Your Hair Loss?

If you have been researching your options and want a clinical assessment rather than another generic recommendation, Carisma Hair Clinic offers a comprehensive diagnostic consultation — scalp imaging, density mapping, and a personalised protocol designed around your specific pattern of loss.

→ Book Your Free Hair Loss Consultation

Dr. Giovanni Scornavacca and the team at Carisma Hair Clinic are available at our St Julian's clinic.

About the Author

Dr. Giovanni Scornavacca is a hair restoration specialist with over 20 years of clinical experience, with advanced training at universities in Rome and Bologna. He leads the Hair Reset Protocol at Carisma Hair Clinic — Malta's most complete non-surgical hair regrowth programme. Dr. Scornavacca specialises in diagnosing and treating androgenetic alopecia, telogen effluvium, and complex hair loss presentations using a combination of PRP, exosome therapy, and prescription protocols tailored to each patient.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Results may vary for each individual. Always consult a qualified healthcare professional before starting any hair loss treatment. Dr. Giovanni Scornavacca and Carisma Hair Clinic are available for clinical consultation at our St Julian's, Malta clinic.

Written and reviewed by Dr. Giovanni Scornavacca, Carisma Hair Clinic. Published: 26 June 2026.

Ready to Take Action?

Book a free consultation with Dr. Giovanni Scornavacca to get a personalised hair loss assessment and treatment plan.